Skip to results

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme (1 selected)

Guidance programme

Showing 676 to 700 of 752

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Bendamustine for the treatment of indolent (low grade) non-Hodgkin's lymphoma that is refractory to rituximab (terminated appraisal)TA206
Temsirolimus for the treatment of relapsed or refractory mantle cell lymphoma (terminated appraisal)TA207
Peginterferon alfa and ribavirin for the treatment of chronic hepatitis CTA200
Adalimumab, etanercept, infliximab, rituximab and abatacept for the treatment of rheumatoid arthritis after the failure of a TNF inhibitorTA195
Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritisTA199
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemiaTA193
Capecitabine for the treatment of advanced gastric cancerTA191
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancerTA192
Human growth hormone (somatropin) for the treatment of growth failure in childrenTA188
Infliximab and adalimumab for the treatment of Crohn's diseaseTA187
Guidance on the use of glycoprotein IIb/IIIa inhibitors in the treatment of acute coronary syndromesTA47
Topotecan for the treatment of relapsed small-cell lung cancerTA184
Topotecan for the treatment of recurrent and stage IVB cervical cancerTA183
Guidance on the use of electroconvulsive therapyTA59
Sunitinib for the treatment of gastrointestinal stromal tumoursTA179
Pemetrexed for the first-line treatment of non-small-cell lung cancerTA181
Alitretinoin for the treatment of severe chronic hand eczemaTA177
Bevacizumab (first-line), sorafenib (first- and second-line), sunitinib (second-line) and temsirolimus (first-line) for the treatment of advanced and/or metastatic renal cell carcinomaTA178
Tenofovir disoproxil for the treatment of chronic hepatitis BTA173
Rituximab for the first-line treatment of chronic lymphocytic leukaemiaTA174
Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adultsTA170
Sunitinib for the first-line treatment of advanced and/or metastatic renal cell carcinomaTA169
Amantadine, oseltamivir and zanamivir for the treatment of influenzaTA168
Machine perfusion systems and cold static storage of kidneys from deceased donorsTA165
Infliximab for acute exacerbations of ulcerative colitisTA163

Results per page

  1. 10
  2. 25
  3. 50
  4. All